4 research outputs found

    Modulation of Na-H antiporter activity in human lymphoblasts by altered membrane cholesterol

    No full text
    The effects of changes in membrane cholesterol on Na-H antiporter activity in culture human lymphoblasts are described. Lymphoblast cholesterol alteration was achieved with liposomes of phosphatidylcholine (cholesterol depletion) or phosphatidylcholine plus cholesterol (cholesterol enrichment). Lymphoblast intracellular pH (pHi) was examined by fluorimetry using cells loaded with the pH-sensitive dye 2',7'-bis(2-carboxyethyl)5(6)-carboxyfluorescein, and the Na-dependent proton efflux rate at a pHi of 6.0 was taken as the maximum velocity of the Na-H antiporter. Lymphoblast membrane cholesterol depletion activated the Na-H antiporter, and enrichment of membrane cholesterol caused inhibition of the antiporter activity. This study demonstrates that in situ modification of membrane cholesterol can modulate the activity of the Na-H antiporter.</jats:p

    Enhancement of NF-κB activity by resveratrol in cytokine-exposed mesangial cells

    No full text
    Resveratrol, a natural polyphenolic phytoalexin, has been considered as a potential anti-inflammatory agent because of its suppressive effect on nuclear factor-κB (NF-κB). However, we recently found that treatment of glomerular mesangial cells with resveratrol significantly and dose-dependently enhanced NF-κB activation triggered by proinflammatory cytokines. This finding was evidenced by different reporter assays as well as by expression of an endogenous NF-κB-dependent gene, intercellular adhesion molecule-1. The NF-κB promoting effect of resveratrol was also observed in renal tubular LLCPK1 cells, but not in HepG2 hepatoma cells. In all cell types tested, treatment with resveratrol alone did not affect NF-κB activity. The enhanced activation of NF-κB by resveratrol progressed for at least 24 h and was accompanied by sustained down-regulation of an endogenous NF-κB inhibitor, IκBβ, but not IκBα. Although expression of inducible nitric oxide synthase was suppressed by resveratrol, nitric oxide, a negative regulator of NF-κB, was not involved in the regulation of NF-κB by resveratrol. These data elucidated, for the first time, that resveratrol may enhance activation of NF-κB under certain circumstances
    corecore